leisure time -WSS

leisure time

author：entertainment 2025-09-28 01:36:48 - browse：22398

Person wearing a blue glove holding money against a blue backdrop. — Adobe

Covid vaccines saved nearly 20 million lives worldwide, by one estimate, and generated billions of dollars for several drugmakers. But investment in experimental vaccines for dozens of other diseases remains modest and should be much higher, according to a new biotechnology industry report.

Even with the historic effort to develop coronavirus vaccines, including shots created by Cambridge, Mass.-based Moderna, drugmakers developing new vaccines for infectious diseases received 3.4% of all venture capital raised for biopharma companies in the past 10 years, for a total of $6.5 billion, the report said.

In comparison, firms with potential cancer drugs received 38% of venture capital, or $72.6 billion — 12 times as much — during the same period, according to the report by the Biotechnology Innovation Organization, or BIO, the world’s largest biotech trade group.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： CMS should re

knowledge

leisure time

WSS

The biotech scorecard for Q4: 16 stock

CRISPR base editing slashes cholesterol levels in monkeys

Pfizer plans to depart BIO

CRISPR base editing slashes cholesterol levels in monkeys

STAT letters to the editor on burnt

Leukemia patients are helped by Syndax's new type of therapy

hotspot

leisure time

leisure time

Malaria cases in Florida and Texas: Here’s what you need to know

Setback for rare diseases as Taysha Gene Therapies pulls back

New air purifier tech could be key to improving indoor air quality

Patients' immediate access to test results puts radiologists in a bind

What does generative AI mean for health care? We asked experts

RSV injection headlines need to be accurate for good uptake

Continuity nursing helped my family in our darkest PICU moments

Congenital heart disease patients face new threat of heart failure

FDA approval of Sarepta Duchenne genetic therapy gives me hope

WHO recommends second malaria vaccine

knowledge

What we owe ALS patients — and why one company fell short

Sanofi says it has 12 blockbusters on the way. Will investors believe it?

WHO recommends second malaria vaccine

Sanofi says it has 12 blockbusters on the way. Will investors believe it?

The stability of $0 premiums in Medicare Advantage

AI models in health care face new federal disclosure requirements

hotspot

knowledge

leisure time

entertainment